Editorial: Game changers in inflammatory bowel diseases, volume II von Lovász, Barbara Dorottya, Bálint, Anita

Volltext

Editorial: Game Changers in Inflammatory Bowel Diseases von Balint, Anita, Lovasz, Barbara Dorottya

Volltext

First prospective European study for the feasibility and safety of magnetically controlled capsule endoscopy in gastric mucosal abnormalities von Szalai, Milán, Helle, Krisztina, Lovász, Barbara Dorottya, Finta, Ádám, Rosztóczy, András, Oczella, László, Madácsy, László

Volltext

Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis von Dubravcsik, Zsolt, Hritz, István, Keczer, Bánk, Novák, Péter, Lovász, Barbara Dorottya, Madácsy, László

Volltext

High‐sensitivity C‐reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: A marker for patient classification? von Sandor Kiss, Lajos, Papp, Maria, Dorottya Lovasz, Barbara, Vegh, Zsuzsanna, Anna Golovics, Petra, Janka, Eszter, Varga, Eva, Szathmari, Miklos, Lakatos, Peter Laszlo

Volltext

Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort von Lovasz, Barbara Dorottya, Lakatos, Laszlo, Horvath, Agnes, Szita, Istvan, Pandur, Tunde, Mandel, Michael, Vegh, Zsuzsanna, Golovics, Petra Anna, Mester, Gabor, Balogh, Mihaly, Molnar, Csaba, Komaromi, Erzsebet, Kiss, Lajos Sandor, Lakatos, Peter Laszlo

Volltext

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies von Gonczi, Lorant, Kurti, Zsuzsanna, Golovics, Petra Anna, Lovasz, Barbara Dorottya, Menyhart, Orsolya, Seres, Anna, Sumegi, Liza Dalma, Gal, Alexander, Ilias, Akos, Janos, Papp, Gecse, Krisztina Barbara, Bessisow, Talat, Afif, Waqqas, Bitton, Alain, Vegh, Zsuzsanna, Lakatos, Peter Laszlo

Volltext

Is early limited surgery associated with a more benign disease course in Crohn's disease? von Golovics, Petra Anna, Lakatos, Laszlo, Nagy, Attila, Pandur, Tunde, Szita, Istvan, Balogh, Mihaly, Molnar, Csaba, Komaromi, Erzsebet, Lovasz, Barbara Dorottya, Mandel, Michael, Veres, Gabor, Kiss, Lajos S, Vegh, Zsuzsanna, Lakatos, Peter Laszlo

Volltext

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Impo... von Gonczi, Lorant, Vegh, Zsuzsanna, Golovics, Petra Anna, Rutka, Mariann, Gecse, Krisztina Barbara, Bor, Renata, Farkas, Klaudia, Szamosi, Tamás, Bene, László, Gasztonyi, Beáta, Kristóf, Tünde, Lakatos, László, Miheller, Pál, Palatka, Károly, Papp, Mária, Patai, Árpád, Salamon, Ágnes, Tóth, Gábor Tamás, Vincze, Áron, Biro, Edina, Lovasz, Barbara Dorottya, Kurti, Zsuzsanna, Szepes, Zoltan, Molnár, Tamás, Lakatos, Péter L.

Volltext

Mo1818 Nationwide Prevalence of Inflammatory Bowel Diseases in Hungary. A Population-Based Study Based on the National Health Insurance Fund Database von Kurti, Zsuzsanna, Gonczi, Lorant, Golovics, Petra A, Lovasz, Barbara Dorottya, Vegh, Zsuzsanna, Lakatos, Peter L

Volltext

Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease von Vegh, Zsuzsanna, Kurti, Zsuzsanna, Gonczi, Lorant, Golovics, Petra Anna, Lovasz, Barbara Dorottya, Szita, Istvan, Balogh, Mihaly, Pandur, Tunde, Vavricka, Stephan R, Rogler, Gerhard, Lakatos, Laszlo, Lakatos, Peter Laszlo

Volltext

Sa1962 Immunogenicity Profile and Predictors of TLs and ADA Development of Biosimilar Infliximab During the First 6 Months of the Therapy: Results From a Prospective Nationwide Coh... von Lovasz, Barbara Dorottya, Kurti, Zsuzsanna, Rutka, Mariann, Vegh, Zsuzsanna, Gecse, Krisztina, Farkas, Klaudia, Lakatos, Laszlo, Miheller, Pal, Palatka, Karoly, Patai, Árpád V, Szamosi, Tamas, Szepes, Zoltan, Vincze, Aron, Molnar, Tamas, Lakatos, Peter L

Volltext

Final Results on Immunogenicity Profile and Predictors of ADA Development of Biosimilar Infliximab During the First 12 Months of the Therapy: Results from a Prospective Nationwide... von Kurti, Zsuzsanna, Lovasz, Barbara Dorottya, Rutka, Mariann, Vegh, Zsuzsanna, Gecse, Krisztina, Farkas, Klaudia, Banai, Jã¡nos, Bene, Laszlo, Golovics, Petra Anna, Gonczi, Lorant, Gasztonyi, Beata, Kristof, Tunde, Lakatos, Laszlo, Miheller, Pal, Palatka, Karoly, Patai, Arpad, Papp, Maria, Salamon, Agnes, Szamosi, Tamas, Szepes, Zoltán, Toth, Gabor Tamas, Vincze, Aron, Szalay, Balazs, Molnar, Tamas, Lakatos, Peter L

Volltext

Final Results on Efficacy and Safety of Biosimilar Infliximab after One-Year: Results from a Prospective Nationwide Cohort von Gecse, Krisztina, Vegh, Zsuzsanna, Kurti, Zsuzsanna, Rutka, Mariann, Farkas, Klaudia, Golovics, Petra Anna, Lovasz, Barbara Dorottya, Gonczi, Lorant, Banai, János, Bene, Laszlo, Gasztonyi, Beata, Kristof, Tunde, Lakatos, Laszlo, Miheller, Pal, Nagy, Ferenc, Palatka, Karoly, Papp, Maria, Patai, Arpad, Salamon, Agnes, Szamosi, Tamas, Szepes, Zoltán, Toth, Gabor Tamas, Vincze, Aron, Molnar, Tamas, Lakatos, Peter L

Volltext

Sa1919 - Final Results on Efficacy and Safety of Biosimilar Infliximab after One-Year: Results from a Prospective Nationwide Cohort von Gecse, Krisztina, Vegh, Zsuzsanna, Kurti, Zsuzsanna, Rutka, Mariann, Farkas, Klaudia, Golovics, Petra Anna, Lovasz, Barbara Dorottya, Gonczi, Lorant, Banai, János, Bene, Laszlo, Gasztonyi, Beata, Kristof, Tunde, Lakatos, Laszlo, Miheller, Pal, Nagy, Ferenc, Palatka, Karoly, Papp, Maria, Patai, Arpad, Salamon, Agnes, Szamosi, Tamas, Szepes, Zoltán, Toth, Gabor Tamas, Vincze, Aron, Molnar, Tamas, Lakatos, Peter L.

Volltext

Sa1900 - Final Results on Immunogenicity Profile and Predictors of ADA Development of Biosimilar Infliximab During the First 12 Months of the Therapy: Results from a Prospective Na... von Kurti, Zsuzsanna, Lovasz, Barbara Dorottya, Rutka, Mariann, Vegh, Zsuzsanna, Gecse, Krisztina, Farkas, Klaudia, Banai, Jã¡nos, Bene, Laszlo, Golovics, Petra Anna, Gonczi, Lorant, Gasztonyi, Beata, Kristof, Tunde, Lakatos, Laszlo, Miheller, Pal, Palatka, Karoly, Patai, Arpad, Papp, Maria, Salamon, Agnes, Szamosi, Tamas, Szepes, Zoltán, Toth, Gabor Tamas, Vincze, Aron, Szalay, Balazs, Molnar, Tamas, Lakatos, Peter L.

Volltext

Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease von Kurti, Zsuzsanna, Lovasz, Barbara Dorottya, Gecse, Krisztina Barbara, Balint, Anita, Farkas, Klaudia, Morocza- Szabo, Agnes, Gyurcsanyi, Andras, Kristof, Katalin, Vegh, Zsuzsanna, Gonczi, Lorant, Kiss, Lajos Sandor, Golovics, Petra Anna, Lakatos, Laszlo, Molnar, Tamas, Lakatos, Peter Laszlo

Volltext

Sa1976 Predicting Short and Medium-Term Efficacy of the Biosimilar Infliximab: Trough Levels/ADAs or Clinical/Biochemical Markers Play a More Important Role? von Golovics, Petra A, Vegh, Zsuzsanna, Rutka, Mariann, Gecse, Krisztina, Balint, Anita, Farkas, Klaudia, Lakatos, Laszlo, Miheller, Pal, Palatka, Karoly, Patai, Árpád V, Szamosi, Tamas, Szepes, Zoltan, Vincze, Aron, Lovasz, Barbara Dorottya, Kurti, Zsuzsanna, Molnar, Tamas, Lakatos, Peter L

Volltext